Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Dr. Abraham Morgentaler

๐Ÿ‘ค Speaker
944 total appearances

Appearances Over Time

Podcast Appearances

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

Then it was guys with radical prostatectomies where they had higher great Gleason scores, higher risk, radiation therapy. Then guys on active surveillance. Now, I wasn't, these guys would seek me out. I wasn't saying to anybody, listen, you really should be on testosterone. No, no, no, no. They came to me, they said, will you give me testosterone?

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

Because they knew about it, or some of them may have been on it before their cancer diagnosis, and they knew how much better they felt. And in the end, I was also giving it to men with metastatic disease and biochemical recurrence. So in 2021, I think it was, we published on 20, 22 guys. who had either biochemical recurrence of their cancer or frank metastatic disease.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

Because they knew about it, or some of them may have been on it before their cancer diagnosis, and they knew how much better they felt. And in the end, I was also giving it to men with metastatic disease and biochemical recurrence. So in 2021, I think it was, we published on 20, 22 guys. who had either biochemical recurrence of their cancer or frank metastatic disease.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

Because they knew about it, or some of them may have been on it before their cancer diagnosis, and they knew how much better they felt. And in the end, I was also giving it to men with metastatic disease and biochemical recurrence. So in 2021, I think it was, we published on 20, 22 guys. who had either biochemical recurrence of their cancer or frank metastatic disease.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And some of those men were on testosterone for years with metastatic disease and not much happened to them. It was just astonishing. So I was nervous with all of them. The first guy that I gave with metastatic disease was an 84-year-old man. And he came to see me. He had widespread METs. His PSA was over 500. And he had done standard treatment with androgen deprivation, and he hated it.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And some of those men were on testosterone for years with metastatic disease and not much happened to them. It was just astonishing. So I was nervous with all of them. The first guy that I gave with metastatic disease was an 84-year-old man. And he came to see me. He had widespread METs. His PSA was over 500. And he had done standard treatment with androgen deprivation, and he hated it.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And some of those men were on testosterone for years with metastatic disease and not much happened to them. It was just astonishing. So I was nervous with all of them. The first guy that I gave with metastatic disease was an 84-year-old man. And he came to see me. He had widespread METs. His PSA was over 500. And he had done standard treatment with androgen deprivation, and he hated it.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And did I say 84? He was 94. But his brain was sharp. And he came from out of state. He said, I've read all. He was a scientist. I've read all your work. I want to come to Boston. Why don't you give me testosterone? And I said to him over the phone, I'm happy to see you, but I can't promise you anything.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And did I say 84? He was 94. But his brain was sharp. And he came from out of state. He said, I've read all. He was a scientist. I've read all your work. I want to come to Boston. Why don't you give me testosterone? And I said to him over the phone, I'm happy to see you, but I can't promise you anything.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And did I say 84? He was 94. But his brain was sharp. And he came from out of state. He said, I've read all. He was a scientist. I've read all your work. I want to come to Boston. Why don't you give me testosterone? And I said to him over the phone, I'm happy to see you, but I can't promise you anything.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And when I saw him, he was mentally sharp, and he could walk, and he had one nephrostomy tube in the pocket. He wore a jacket. He had one nephrostomy tube bag in one pocket of his jacket, another one in the other pocket. I said, what do you want testosterone for? He says, I used to exercise every day and it made me feel good.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And when I saw him, he was mentally sharp, and he could walk, and he had one nephrostomy tube in the pocket. He wore a jacket. He had one nephrostomy tube bag in one pocket of his jacket, another one in the other pocket. I said, what do you want testosterone for? He says, I used to exercise every day and it made me feel good.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And when I saw him, he was mentally sharp, and he could walk, and he had one nephrostomy tube in the pocket. He wore a jacket. He had one nephrostomy tube bag in one pocket of his jacket, another one in the other pocket. I said, what do you want testosterone for? He says, I used to exercise every day and it made me feel good.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And I've got colleagues in science around the world and I'm just too tired to correspond with them. He says, those were the two main things that gave me pleasure in life and I'd like to be able to do them again. And I said, you know, I've never treated anybody like you. You could die in a week tomorrow if I give you a testosterone. And he said, I've never lived my life in fear.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And I've got colleagues in science around the world and I'm just too tired to correspond with them. He says, those were the two main things that gave me pleasure in life and I'd like to be able to do them again. And I said, you know, I've never treated anybody like you. You could die in a week tomorrow if I give you a testosterone. And he said, I've never lived my life in fear.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And I've got colleagues in science around the world and I'm just too tired to correspond with them. He says, those were the two main things that gave me pleasure in life and I'd like to be able to do them again. And I said, you know, I've never treated anybody like you. You could die in a week tomorrow if I give you a testosterone. And he said, I've never lived my life in fear.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

I don't intend to do it now. He says, and besides, I'm 94 years old. I'm going to die. He says, I've got metastatic prostate cancer. I'm probably going to die from that. But he said, while I'm alive, I'd like to live as well as I can. And he said, I'll sign anything that you want. And so I wrote this very long handwritten note in his chart. And I treated him.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

I don't intend to do it now. He says, and besides, I'm 94 years old. I'm going to die. He says, I've got metastatic prostate cancer. I'm probably going to die from that. But he said, while I'm alive, I'd like to live as well as I can. And he said, I'll sign anything that you want. And so I wrote this very long handwritten note in his chart. And I treated him.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

I don't intend to do it now. He says, and besides, I'm 94 years old. I'm going to die. He says, I've got metastatic prostate cancer. I'm probably going to die from that. But he said, while I'm alive, I'd like to live as well as I can. And he said, I'll sign anything that you want. And so I wrote this very long handwritten note in his chart. And I treated him.

BackTable Urology
Ep. 188 Testosterone Therapy Today: Clinical Advances and Safety with Dr. Abraham Morgentaler

And within a few weeks, he was exercising. He gained weight, which he needed. He was very skinny. His appetite came back. He started corresponding with his colleagues. And he had a bunch of patents. He started to work on a new patent. He had a good year. And we died at the end of the year. But I don't think we shortened his life expectancy by one day. And he died of prostate cancer.